Arkolith/Insider Trading/EMMA/Form 4

Niihara Yutaka

Chairman and CEO, Director, 10% OwnerEmmaus Life Sciences, Inc. (EMMA) · full profile →Form 4 · filed Oct 24, 2022
Net Buying
Open-Market Buys
$11K
Open-Market Sells
$0
Net Open-Market Flow
$11K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 21, 2022Buy(P)10K$0.19$2K11.9M
Oct 20, 2022Buy(P)30K$0.18$5K11.9M
Oct 19, 2022Buy(P)25K$0.16$4K11.9M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-054449) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML